{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:08:09Z","timestamp":1790633289664,"version":"4.1.0"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Matrix Biology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.matbio.2018.01.023","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T15:38:22Z","timestamp":1517499502000},"page":"404-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"special_numbering":"C","title":["Biomarkers in idiopathic pulmonary fibrosis"],"prefix":"10.1016","volume":"68-69","author":[{"given":"F.","family":"Drakopanagiotakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Wujak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Wygrecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Markart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.matbio.2018.01.023_bb0005","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.matbio.2018.01.023_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12916-016-0567-9","article-title":"Guidelines or guidance for better idiopathic pulmonary fibrosis management?","volume":"14","author":"Behr","year":"2016","journal-title":"BMC Med."},{"issue":"9991","key":"10.1016\/j.matbio.2018.01.023_bb0015","first-page":"312","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.matbio.2018.01.023_bb0020","first-page":"82","article-title":"Taking a giant step in the diagnosis of idiopathic pulmonary fibrosis","volume":"6, No. 2","author":"Tzilas","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.matbio.2018.01.023_bb0025","first-page":"138","article-title":"Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper","volume":"6, No. 2","author":"Lynch","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.matbio.2018.01.023_bb0030","article-title":"Idiopathic pulmonary fibrosis","volume":"3","author":"Martinez","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0035","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00936-2017","article-title":"Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study","volume":"50","author":"Walsh","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.matbio.2018.01.023_bb0040","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd.2017.170","article-title":"Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease","volume":"16","author":"Mora","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.matbio.2018.01.023_bb0045","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/MCP.0000000000000289","article-title":"Pharmacogenetics and interstitial lung disease","volume":"22","author":"Oldham","year":"2016","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1183\/09031936.00200614","article-title":"A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials","volume":"46","author":"Collard","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.matbio.2018.01.023_bb0055","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000475780","article-title":"Idiopathic pulmonary fibrosis: molecular endotypes of fibrosis stratifying existing and emerging therapies","volume":"93","author":"Magnini","year":"2017","journal-title":"Respiration"},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0060","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/aa840a","article-title":"Exhaled breath condensate as a potential biomarker tool for idiopathic pulmonary fibrosis-a pilot study","volume":"12","author":"Rindlisbacher","year":"2017","journal-title":"J. Breath Res."},{"issue":"14","key":"10.1016\/j.matbio.2018.01.023_bb0065","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2174\/1568026616666150930120959","article-title":"Biomarkers in the evaluation and management of idiopathic pulmonary fibrosis","volume":"16","author":"Tzouvelekis","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171344","article-title":"Sputum biomarkers in IPF: evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7","volume":"12","author":"Guiot","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.matbio.2018.01.023_bb0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00408-017-9993-5","article-title":"Blood biomarkers in idiopathic pulmonary fibrosis","volume":"195","author":"Guiot","year":"2017","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0080","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00408-017-9979-3","article-title":"Volatile organic compounds in exhaled breath of idiopathic pulmonary fibrosis for discrimination from healthy subjects","volume":"195","author":"Yamada","year":"2017","journal-title":"Lung"},{"key":"10.1016\/j.matbio.2018.01.023_bb0085","first-page":"122","article-title":"Biomarkers, in monograph: idiopathic pulmonary fibrosis","author":"Kokosi","year":"2016","journal-title":"Eur. Res. Soc."},{"key":"10.1016\/j.matbio.2018.01.023_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13069-015-0020-2","article-title":"Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis","volume":"8","author":"Kaarteenaho","year":"2015","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"5","key":"10.1016\/j.matbio.2018.01.023_bb0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/MCP.0000000000000187","article-title":"Personalized medicine in idiopathic pulmonary fibrosis: facts and promises","volume":"21","author":"Spagnolo","year":"2015","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"7","key":"10.1016\/j.matbio.2018.01.023_bb0100","first-page":"661","article-title":"Idiopathic pulmonary fibrosis: are any of the morphological-molecular markers useful in clinical management?","volume":"32","author":"Lunardi","year":"2017","journal-title":"Histol. Histopathol."},{"issue":"9","key":"10.1016\/j.matbio.2018.01.023_bb0105","first-page":"L681","article-title":"Molecular biomarkers in idiopathic pulmonary fibrosis","volume":"307","author":"Ley","year":"2014","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"7","key":"10.1016\/j.matbio.2018.01.023_bb0110","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/resp.12569","article-title":"Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers","volume":"20","author":"Hambly","year":"2015","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-134-2-200101160-00015","article-title":"Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy","volume":"134","author":"Selman","year":"2001","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.matbio.2018.01.023_bb0120","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm.164.6.2001056","article-title":"Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality","volume":"164","author":"King","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.matbio.2018.01.023_bb0125","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1513\/pats.201201-003AW","article-title":"TGF-beta activation and lung fibrosis","volume":"9","author":"Tatler","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"10","key":"10.1016\/j.matbio.2018.01.023_bb0130","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/rccm.201312-2221PP","article-title":"Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model","volume":"189","author":"Selman","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.matbio.2018.01.023_bb0135","first-page":"L590","article-title":"Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis","volume":"311","author":"O'Dwyer","year":"2016","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.matbio.2018.01.023_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14532","article-title":"Cellular senescence mediates fibrotic pulmonary disease","volume":"8","author":"Schafer","year":"2017","journal-title":"Nat. Commun."},{"issue":"5 Pt 1","key":"10.1016\/j.matbio.2018.01.023_bb0145","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1164\/ajrccm.158.5.9803115","article-title":"Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis","volume":"158","author":"Yokoyama","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.matbio.2018.01.023_bb0150","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.rmed.2015.10.005","article-title":"The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis","volume":"109","author":"Okamoto","year":"2015","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/15412555.2017.1278753","article-title":"Differing expression of cytokines and tumor markers in combined pulmonary fibrosis and emphysema compared to emphysema and pulmonary fibrosis","volume":"14","author":"Xu","year":"2017","journal-title":"COPD"},{"key":"10.1016\/j.matbio.2018.01.023_bb0160","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4759040","article-title":"Comparative study of circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as disease markers of idiopathic pulmonary fibrosis","volume":"2016","author":"Hamai","year":"2016","journal-title":"Dis. Markers"},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0165","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1440-1843.2006.00834.x","article-title":"Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis","volume":"11","author":"Yokoyama","year":"2006","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0170","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.resinv.2016.09.003","article-title":"Prognostic value of serial serum KL-6 measurements in patients with idiopathic pulmonary fibrosis","volume":"55","author":"Wakamatsu","year":"2017","journal-title":"Respir. Investig."},{"issue":"3","key":"10.1016\/j.matbio.2018.01.023_bb0175","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00019-2016","article-title":"Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis","volume":"3","author":"Sokai","year":"2017","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.matbio.2018.01.023_bb0180","first-page":"1","article-title":"Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"00","author":"Qiu","year":"2017","journal-title":"Clin. Respir. J."},{"issue":"7","key":"10.1016\/j.matbio.2018.01.023_bb0185","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.rmed.2014.04.009","article-title":"Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis","volume":"108","author":"Ohshimo","year":"2014","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.matbio.2018.01.023_bb0190","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/ajrccm\/148.3.637","article-title":"KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease","volume":"148","author":"Kohno","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"issue":"124","key":"10.1016\/j.matbio.2018.01.023_bb0195","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1183\/09059180.00001012","article-title":"Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis","volume":"21","author":"Gunther","year":"2012","journal-title":"Eur. Respir. Rev."},{"issue":"6","key":"10.1016\/j.matbio.2018.01.023_bb0200","first-page":"L507","article-title":"Lost after translation: insights from pulmonary surfactant for understanding the role of alveolar epithelial dysfunction and cellular quality control in fibrotic lung disease","volume":"309","author":"Mulugeta","year":"2015","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"6","key":"10.1016\/j.matbio.2018.01.023_bb0205","first-page":"L1119","article-title":"Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection","volume":"294","author":"Lawson","year":"2008","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"8","key":"10.1016\/j.matbio.2018.01.023_bb0210","first-page":"L721","article-title":"Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis","volume":"302","author":"Tanjore","year":"2012","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"8","key":"10.1016\/j.matbio.2018.01.023_bb0215","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1164\/rccm.200802-313OC","article-title":"Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis","volume":"178","author":"Korfei","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6 Pt 1","key":"10.1016\/j.matbio.2018.01.023_bb0220","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1164\/ajrccm.152.6.8520747","article-title":"Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids","volume":"152","author":"Honda","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.matbio.2018.01.023_bb0225","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1164\/ajrccm\/147.3.723","article-title":"Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis","volume":"147","author":"Kuroki","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"issue":"3","key":"10.1016\/j.matbio.2018.01.023_bb0230","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1183\/09031936.02.00081102","article-title":"Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis","volume":"19","author":"Greene","year":"2002","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.matbio.2018.01.023_bb0235","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1034\/j.1399-3003.1999.14c14.x","article-title":"Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis","volume":"14","author":"Gunther","year":"1999","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0240","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1164\/ajrccm.152.2.7633738","article-title":"Surfactant protein A predicts survival in idiopathic pulmonary fibrosis","volume":"152","author":"McCormack","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"Suppl","key":"10.1016\/j.matbio.2018.01.023_bb0245","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1111\/j.1440-1843.2006.00809.x","article-title":"Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D","volume":"11","author":"Takahashi","year":"2006","journal-title":"Respirology"},{"issue":"3 Pt 1","key":"10.1016\/j.matbio.2018.01.023_bb0250","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1164\/ajrccm.162.3.9910080","article-title":"Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent","volume":"162","author":"Takahashi","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0255","first-page":"L3","article-title":"Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis","volume":"299","author":"Collard","year":"2010","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"23","key":"10.1016\/j.matbio.2018.01.023_bb0260","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007083","article-title":"Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0265","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1513\/pats.201008-056MS","article-title":"Idiopathic pulmonary fibrosis: update on genetic discoveries","volume":"8","author":"Garcia","year":"2011","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"8","key":"10.1016\/j.matbio.2018.01.023_bb0270","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/hmg\/ddw014","article-title":"Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer","volume":"25","author":"Nathan","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0275","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajhg.2008.11.010","article-title":"Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer","volume":"84","author":"Wang","year":"2009","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0280","first-page":"L181","article-title":"Mucociliary interactions and mucus dynamics in ciliated human bronchial epithelial cell cultures","volume":"301","author":"Sears","year":"2011","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0285","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1165\/ajrcmb.19.1.3054","article-title":"MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways","volume":"19","author":"Sharma","year":"1998","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.matbio.2018.01.023_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058658","article-title":"The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium","volume":"8","author":"Seibold","year":"2013","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.matbio.2018.01.023_bb0295","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","article-title":"A common MUC5B promoter polymorphism and pulmonary fibrosis","volume":"364","author":"Seibold","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.matbio.2018.01.023_bb0300","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S2213-2600(13)70045-6","article-title":"Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study","volume":"1","author":"Noth","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.matbio.2018.01.023_bb0305","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ng.2609","article-title":"Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis","volume":"45","author":"Fingerlin","year":"2013","journal-title":"Nat. Genet."},{"issue":"21","key":"10.1016\/j.matbio.2018.01.023_bb0310","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1001\/jama.2013.5827","article-title":"Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis","volume":"309","author":"Peljto","year":"2013","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.matbio.2018.01.023_bb0315","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMc1013504","article-title":"A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis","volume":"364","author":"Zhang","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.matbio.2018.01.023_bb0320","article-title":"Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.matbio.2018.01.023_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070621","article-title":"The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population","volume":"8","author":"Borie","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.matbio.2018.01.023_bb0330","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.chest.2015.11.009","article-title":"CT imaging phenotypes of pulmonary fibrosis in the MUC5B promoter site polymorphism","volume":"149","author":"Chung","year":"2016","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.matbio.2018.01.023_bb0335","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/thoraxjnl-2012-201786","article-title":"Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis","volume":"68","author":"Stock","year":"2013","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.matbio.2018.01.023_bb0340","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S2213-2600(17)30216-3","article-title":"The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study","volume":"5","author":"Ley","year":"2017","journal-title":"Lancet Respir. Med."},{"issue":"23","key":"10.1016\/j.matbio.2018.01.023_bb0345","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1056\/NEJMoa1216076","article-title":"MUC5B promoter polymorphism and interstitial lung abnormalities","volume":"368","author":"Hunninghake","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.matbio.2018.01.023_bb0350","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1164\/rccm.201512-2523OC","article-title":"Development and progression of interstitial lung abnormalities in the Framingham heart study","volume":"194","author":"Araki","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.matbio.2018.01.023_bb0355","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.chest.2017.04.185","article-title":"Clinical and genetic associations of objectively identified interstitial changes in smokers","volume":"152","author":"Ash","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.matbio.2018.01.023_bb0360","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1465-9921-13-105","article-title":"Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis","volume":"13","author":"Cha","year":"2012","journal-title":"Respir. Res."},{"issue":"7","key":"10.1016\/j.matbio.2018.01.023_bb0365","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-2600(14)70140-7","article-title":"Short telomeres: a repeat offender in IPF","volume":"2","author":"Stanley","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.matbio.2018.01.023_bb0370","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10522-013-9451-6","article-title":"Mechanistic links between aging and lung fibrosis","volume":"14","author":"Thannickal","year":"2013","journal-title":"Biogerontology"},{"issue":"1-2","key":"10.1016\/j.matbio.2018.01.023_bb0375","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mrfmmm.2011.10.013","article-title":"Telomerase and idiopathic pulmonary fibrosis","volume":"730","author":"Armanios","year":"2012","journal-title":"Mutat. Res."},{"issue":"14","key":"10.1016\/j.matbio.2018.01.023_bb0380","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86704","article-title":"Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis","volume":"1","author":"Naikawadi","year":"2016","journal-title":"JCI Insight"},{"issue":"13","key":"10.1016\/j.matbio.2018.01.023_bb0385","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa066157","article-title":"Telomerase mutations in families with idiopathic pulmonary fibrosis","volume":"356","author":"Armanios","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.matbio.2018.01.023_bb0390","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0701009104","article-title":"Adult-onset pulmonary fibrosis caused by mutations in telomerase","volume":"104","author":"Tsakiri","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"35","key":"10.1016\/j.matbio.2018.01.023_bb0395","doi-asserted-by":"crossref","first-page":"13051","DOI":"10.1073\/pnas.0804280105","article-title":"Short telomeres are a risk factor for idiopathic pulmonary fibrosis","volume":"105","author":"Alder","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0400","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1164\/rccm.201610-2088OC","article-title":"An exome sequencing study to assess the role of rare genetic variation in pulmonary fibrosis","volume":"196","author":"Petrovski","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0405","doi-asserted-by":"crossref","DOI":"10.1378\/chest.13-2224","article-title":"A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia","volume":"146","author":"Kropski","year":"2014","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.matbio.2018.01.023_bb0410","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.healun.2014.11.010","article-title":"Severe hematologic complications after lung transplantation in patients with telomerase complex mutations","volume":"34","author":"Borie","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"10.1016\/j.matbio.2018.01.023_bb0415","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1164\/rccm.200804-550OC","article-title":"Telomere shortening in familial and sporadic pulmonary fibrosis","volume":"178","author":"Cronkhite","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.matbio.2018.01.023_bb0420","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1183\/09031936.02.00022302","article-title":"Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF","volume":"20","author":"Henry","year":"2002","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.matbio.2018.01.023_bb0425","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1165\/ajrcmb.24.5.4333","article-title":"Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression","volume":"24","author":"Ramos","year":"2001","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.matbio.2018.01.023_bb0430","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1164\/ajrccm.162.5.9906096","article-title":"Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias","volume":"162","author":"Suga","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.matbio.2018.01.023_bb0435","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1183\/09031936.00024711","article-title":"Metalloproteinases in idiopathic pulmonary fibrosis","volume":"38","author":"Dancer","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.matbio.2018.01.023_bb0440","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1165\/rcmb.2015-0020TR","article-title":"Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis","volume":"53","author":"Craig","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.matbio.2018.01.023_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050093","article-title":"MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis","volume":"5","author":"Rosas","year":"2008","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.matbio.2018.01.023_bb0450","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/resp.12920","article-title":"Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis","volume":"22","author":"Tzouvelekis","year":"2017","journal-title":"Respirology"},{"issue":"8","key":"10.1016\/j.matbio.2018.01.023_bb0455","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.rmed.2015.06.003","article-title":"Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias","volume":"109","author":"Morais","year":"2015","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0460","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00074-2016","article-title":"MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis","volume":"3","author":"Bauer","year":"2017","journal-title":"ERJ Open Res."},{"issue":"5","key":"10.1016\/j.matbio.2018.01.023_bb0465","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1378\/chest.11-2735","article-title":"Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis","volume":"143","author":"Song","year":"2013","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.matbio.2018.01.023_bb0470","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1164\/rccm.201701-0254OC","article-title":"Serum matrix metalloproteinase-7, respiratory symptoms, and mortality in community-dwelling adults: the multi-ethnic study of atherosclerosis","volume":"196","author":"Armstrong","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0475","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41598-017-00270-0","article-title":"Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis","volume":"7","author":"Aumiller","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.matbio.2018.01.023_bb0480","article-title":"ECM crosslinking enhances fibroblast growth and protects against matrix proteolysis in lung fibrosis","author":"Philp","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.matbio.2018.01.023_bb0485","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1183\/09031936.00141013","article-title":"Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression","volume":"43","author":"Chien","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0490","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2213-2600(16)30421-0","article-title":"Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial","volume":"5","author":"Raghu","year":"2017","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0495","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03403533","article-title":"Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair","volume":"1","author":"Bucala","year":"1994","journal-title":"Mol. Med."},{"issue":"10","key":"10.1016\/j.matbio.2018.01.023_bb0500","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.biocel.2008.02.012","article-title":"Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis","volume":"40","author":"Andersson-Sjoland","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"7","key":"10.1016\/j.matbio.2018.01.023_bb0505","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1164\/rccm.200810-1534OC","article-title":"Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis","volume":"179","author":"Moeller","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.matbio.2018.01.023_bb0510","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/1817-1737.157294","article-title":"Rapid detection of circulating fibrocytes by flowcytometry in idiopathic pulmonary fibrosis","volume":"10","author":"Alhamad","year":"2015","journal-title":"Ann. Thorac. Med."},{"key":"10.1016\/j.matbio.2018.01.023_bb0515","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/gt.2017.80","article-title":"Oligonucleotides targeting periostin ameliorates pulmonary fibrosis","volume":"24","author":"Tomaru","year":"2017","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.matbio.2018.01.023_bb0520","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1183\/09031936.00059810","article-title":"Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias","volume":"37","author":"Okamoto","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.matbio.2018.01.023_bb0525","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pupt.2017.05.007","article-title":"IL-13 and idiopathic pulmonary fibrosis: possible links and new therapeutic strategies","volume":"45","author":"Passalacqua","year":"2017","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0530","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.resinv.2014.12.003","article-title":"Serum level of periostin can predict long-term outcome of idiopathic pulmonary fibrosis","volume":"53","author":"Tajiri","year":"2015","journal-title":"Res. Invest."},{"issue":"12","key":"10.1016\/j.matbio.2018.01.023_bb0535","first-page":"L1046","article-title":"Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis","volume":"303","author":"Naik","year":"2012","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"3","key":"10.1016\/j.matbio.2018.01.023_bb0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174547","article-title":"Consortium for development of diagnostics for pulmonary fibrosis, the usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis","volume":"12","author":"Ohta","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.matbio.2018.01.023_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020251","article-title":"Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis","volume":"2","author":"Pardo","year":"2005","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0550","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.rmed.2004.04.018","article-title":"High plasma concentrations of osteopontin in patients with interstitial pneumonia","volume":"99","author":"Kadota","year":"2005","journal-title":"Respir. Med."},{"issue":"10","key":"10.1016\/j.matbio.2018.01.023_bb0555","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1164\/rccm.201505-0862OC","article-title":"Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias","volume":"194","author":"White","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.matbio.2018.01.023_bb0560","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.200808-1201OC","article-title":"Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis","volume":"179","author":"Prasse","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.matbio.2018.01.023_bb0565","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00408-014-9647-9","article-title":"Evaluation of circulating YKL-40 levels in idiopathic interstitial pneumonias","volume":"192","author":"Korthagen","year":"2014","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0570","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01924-2015","article-title":"Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis","volume":"49","author":"Long","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.matbio.2018.01.023_bb0575","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3899\/jrheum.170373","article-title":"Clinical utility of YKL-40 in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"44","author":"Hozumi","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.matbio.2018.01.023_bb0580","doi-asserted-by":"crossref","first-page":"1797512","DOI":"10.1155\/2017\/1797512","article-title":"Glycoprotein YKL-40 levels in plasma are associated with fibrotic changes on HRCT in asbestos-exposed subjects","volume":"2017","author":"Vaananen","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0585","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.rmed.2010.09.012","article-title":"Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis","volume":"105","author":"Korthagen","year":"2011","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.matbio.2018.01.023_bb0590","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1517\/14728222.2014.988706","article-title":"Targeting defective toll-like receptor-3 function and idiopathic pulmonary fibrosis","volume":"19","author":"O'Dwyer","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"issue":"12","key":"10.1016\/j.matbio.2018.01.023_bb0595","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1164\/rccm.201304-0760OC","article-title":"The toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis","volume":"188","author":"O'Dwyer","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.matbio.2018.01.023_bb0600","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1164\/rccm.201505-1010OC","article-title":"TOLLIP, MUC5B, and the response to N-acetylcysteine among individuals with idiopathic pulmonary fibrosis","volume":"192","author":"Oldham","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.matbio.2018.01.023_bb0605","first-page":"L1094","article-title":"RAGE: developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells","volume":"294","author":"Reynolds","year":"2008","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0610","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaci.2006.08.021","article-title":"S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity","volume":"119","author":"Yang","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.matbio.2018.01.023_bb0615","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/01.CCM.0000262386.32287.29","article-title":"Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome","volume":"35","author":"Wittkowski","year":"2007","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.matbio.2018.01.023_bb0620","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1165\/rcmb.2007-0244OC","article-title":"Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types","volume":"39","author":"Queisser","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0625","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1164\/rccm.201101-0058OC","article-title":"Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis","volume":"185","author":"Richards","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.matbio.2018.01.023_bb0630","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF03256616","article-title":"The role of defensins in lung biology and therapy","volume":"1","author":"Cole","year":"2002","journal-title":"Am. J. Respir. Med."},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0635","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1164\/rccm.200810-1596OC","article-title":"Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis","volume":"180","author":"Konishi","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.matbio.2018.01.023_bb0640","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/thorax.57.7.623","article-title":"Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis","volume":"57","author":"Mukae","year":"2002","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0645","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.rmed.2014.12.015","article-title":"Elevated plasma alpha-defensins in patients with acute exacerbation of fibrotic interstitial pneumonia","volume":"109","author":"Sakamoto","year":"2015","journal-title":"Respir. Med."},{"issue":"7","key":"10.1016\/j.matbio.2018.01.023_bb0650","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1164\/rccm.201203-0506OC","article-title":"Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses","volume":"187","author":"Kahloon","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.matbio.2018.01.023_bb0655","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.bcp.2010.05.025","article-title":"Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice","volume":"80","author":"Tanaka","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0660","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/thoraxjnl-2013-204596","article-title":"Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis","volume":"70","author":"DePianto","year":"2015","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.matbio.2018.01.023_bb0665","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1164\/rccm.201309-1592OC","article-title":"C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis","volume":"189","author":"Vuga","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.matbio.2018.01.023_bb0670","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.4049\/jimmunol.1700473","article-title":"Autoimmunity to vimentin is associated with outcomes of patients with idiopathic pulmonary fibrosis","volume":"199","author":"Li","year":"2017","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.matbio.2018.01.023_bb0675","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.4049\/jimmunol.179.4.2592","article-title":"Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis","volume":"179","author":"Feghali-Bostwick","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008959","article-title":"CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis","volume":"5","author":"Gilani","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0685","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/039463201002300207","article-title":"Decreased interstitial FOXP3(+) lymphocytes in usual interstitial pneumonia with discrepancy of CXCL12\/CXCR4 axis","volume":"23","author":"Shimizu","year":"2010","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"205","key":"10.1016\/j.matbio.2018.01.023_bb0690","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005964","article-title":"Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis","volume":"5","author":"Herazo-Maya","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.matbio.2018.01.023_bb0695","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/thoraxjnl-2016-208423","article-title":"Pulmonary CCR2+CD4+ T cells are immune regulatory and attenuate lung fibrosis development","volume":"72","author":"Milger","year":"2017","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.matbio.2018.01.023_bb0700","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1164\/rccm.200812-1936OC","article-title":"Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis","volume":"179","author":"Kotsianidis","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0705","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.201206-1109OC","article-title":"Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-beta1-induced pulmonary fibrosis","volume":"187","author":"Reilkoff","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0710","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12931-017-0653-3","article-title":"Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis","volume":"18","author":"Hou","year":"2017","journal-title":"Respir. Res."},{"issue":"12","key":"10.1016\/j.matbio.2018.01.023_bb0715","doi-asserted-by":"crossref","first-page":"250","DOI":"10.21037\/atm.2017.01.56","article-title":"The respiratory microbiome in idiopathic pulmonary fibrosis","volume":"5","author":"Hewitt","year":"2017","journal-title":"Ann. Transl. Med."},{"issue":"7","key":"10.1016\/j.matbio.2018.01.023_bb0720","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S2213-2600(14)70088-8","article-title":"Respiratory microbiome in IPF: cause, effect, or biomarker?","volume":"2","author":"Molyneaux","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"8","key":"10.1016\/j.matbio.2018.01.023_bb0725","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1164\/rccm.201403-0541OC","article-title":"The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis","volume":"190","author":"Molyneaux","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.matbio.2018.01.023_bb0730","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S2213-2600(14)70069-4","article-title":"Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study","volume":"2","author":"Han","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.matbio.2018.01.023_bb0735","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02086-2016","article-title":"The microbiome in respiratory medicine: current challenges and future perspectives","volume":"49","author":"Faner","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0740","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.201607-1525OC","article-title":"Microbes are associated with host innate immune response in idiopathic pulmonary fibrosis","volume":"196","author":"Huang","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.matbio.2018.01.023_bb0745","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12931-017-0511-3","article-title":"Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis","volume":"18","author":"Molyneaux","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.matbio.2018.01.023_bb0750","article-title":"Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis","author":"Kitsios","year":"2017","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0755","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1139\/bcb-2014-0126","article-title":"Epigenetics in idiopathic pulmonary fibrosis","volume":"93","author":"Tzouvelekis","year":"2015","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.matbio.2018.01.023_bb0760","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1165\/rcmb.2017-0133OC","article-title":"MicroRNA-29c prevents pulmonary fibrosis by regulating epithelial cell renewal and apoptosis","volume":"57","author":"Xie","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0765","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1139\/bcb-2014-0095","article-title":"The role of miR-29 in pulmonary fibrosis","volume":"93","author":"Cushing","year":"2015","journal-title":"Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0770","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1164\/rccm.200911-1698OC","article-title":"Inhibition and role of let-7d in idiopathic pulmonary fibrosis","volume":"182","author":"Pandit","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.matbio.2018.01.023_bb0775","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.trsl.2011.01.012","article-title":"MicroRNAs in idiopathic pulmonary fibrosis","volume":"157","author":"Pandit","year":"2011","journal-title":"Transl. Res."},{"issue":"9","key":"10.1016\/j.matbio.2018.01.023_bb0780","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3109\/02770903.2013.822080","article-title":"Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis","volume":"50","author":"Li","year":"2013","journal-title":"J. Asthma"},{"issue":"6","key":"10.1016\/j.matbio.2018.01.023_bb0785","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1165\/rcmb.2011-0377OC","article-title":"Profibrotic role of miR-154 in pulmonary fibrosis","volume":"47","author":"Milosevic","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.matbio.2018.01.023_bb0790","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI64125","article-title":"The role of mitochondria in aging","volume":"123","author":"Bratic","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.matbio.2018.01.023_bb0795","doi-asserted-by":"crossref","first-page":"21486","DOI":"10.3390\/ijms160921486","article-title":"The role of mitochondrial DNA in mediating alveolar epithelial cell apoptosis and pulmonary fibrosis","volume":"16","author":"Kim","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0800","first-page":"L433","article-title":"Differential regulation of autophagy and mitophagy in pulmonary diseases","volume":"311","author":"Aggarwal","year":"2016","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"2","key":"10.1016\/j.matbio.2018.01.023_bb0805","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI74942","article-title":"PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis","volume":"125","author":"Bueno","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.matbio.2018.01.023_bb0810","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.277","article-title":"Mitochondria released by cells undergoing TNF-alpha-induced necroptosis act as danger signals","volume":"5","author":"Maeda","year":"2014","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.matbio.2018.01.023_bb0815","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI83885","article-title":"Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9","volume":"126","author":"Garcia-Martinez","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.matbio.2018.01.023_bb0820","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.freeradbiomed.2015.02.034","article-title":"Intratracheal administration of mitochondrial DNA directly provokes lung inflammation through the TLR9-p38 MAPK pathway","volume":"83","author":"Gu","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.matbio.2018.01.023_bb0825","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajpath.2014.12.011","article-title":"Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: Possible implications in idiopathic pulmonary fibrosis","volume":"185","author":"Kirillov","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.matbio.2018.01.023_bb0830","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/path.4359","article-title":"Neutrophil extracellular traps promote differentiation and function of fibroblasts","volume":"233","author":"Chrysanthopoulou","year":"2014","journal-title":"J. Pathol."},{"issue":"12","key":"10.1016\/j.matbio.2018.01.023_bb0835","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1097\/CCM.0000000000001311","article-title":"Mitochondrial DNA and toll-like Receptor-9 are associated with mortality in critically ill patients","volume":"43","author":"Krychtiuk","year":"2015","journal-title":"Crit. Care Med."},{"issue":"12","key":"10.1016\/j.matbio.2018.01.023_bb0840","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1164\/rccm.201612-2480OC","article-title":"Extracellular mitochondrial DNA is generated by fibroblasts and predicts death in idiopathic pulmonary fibrosis","volume":"196","author":"Ryu","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.matbio.2018.01.023_bb0845","doi-asserted-by":"crossref","first-page":"806014","DOI":"10.1155\/2011\/806014","article-title":"A normal range of KL-6\/MUC1 independent of elevated SP-D indicates a better prognosis in the patients with honeycombing on high-resolution computed tomography","volume":"2011","author":"Hisata","year":"2011","journal-title":"Pulm. Med."},{"issue":"6","key":"10.1016\/j.matbio.2018.01.023_bb0850","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021253","article-title":"A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis","volume":"6","author":"Oak","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.matbio.2018.01.023_bb0855","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40291-014-0109-0","article-title":"Molecular biomarkers in interstitial lung diseases","volume":"18","author":"De Lauretis","year":"2014","journal-title":"Mol. Diagn. Ther."},{"issue":"145","key":"10.1016\/j.matbio.2018.01.023_bb0860","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0051-2017","article-title":"Evaluating disease severity in idiopathic pulmonary fibrosis","volume":"26","author":"Robbie","year":"2017","journal-title":"Eur. Respir. Rev."},{"issue":"6","key":"10.1016\/j.matbio.2018.01.023_bb0865","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1378\/chest.08-2209","article-title":"Serum surfactant protein-a is a strong predictor of early mortality in idiopathic pulmonary fibrosis","volume":"135","author":"Kinder","year":"2009","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.matbio.2018.01.023_bb0870","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S2213-2600(17)30430-7","article-title":"An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study","volume":"5","author":"Maher","year":"2017","journal-title":"Lancet Respir. Med."},{"issue":"11","key":"10.1016\/j.matbio.2018.01.023_bb0875","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S2213-2600(17)30349-1","article-title":"Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study","volume":"5","author":"Herazo-Maya","year":"2017","journal-title":"Lancet Respir. Med."},{"issue":"17","key":"10.1016\/j.matbio.2018.01.023_bb0880","first-page":"30168","article-title":"Alternatives to current flow cytometry data analysis for clinical and research studies","volume":"S1046-2023","author":"Gondhalekar","year":"2018","journal-title":"Methods"}],"container-title":["Matrix Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0945053X17304043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0945053X17304043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T22:18:41Z","timestamp":1719785921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0945053X17304043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":176,"alternative-id":["S0945053X17304043"],"URL":"https:\/\/doi.org\/10.1016\/j.matbio.2018.01.023","relation":{},"ISSN":["0945-053X"],"issn-type":[{"value":"0945-053X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers in idiopathic pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"Matrix Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.matbio.2018.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}